The National Pharmaceutical Pricing Authority (NPPA) has decided to increase the maximum price of 8 scheduled medicines. These medicines are used to cure many other diseases including asthma, TB, glaucoma. The Ministry of Health and Family Affairs said that the NPPA has approved the increase in the maximum prices of eleven scheduled formulations of eight medicines by up to 50% from their current maximum prices. Earlier, the NPPA had decided to increase the prices of 21 and 9 formulation medicines by 50% in 2019 and 2020. The government has revised the prices of these medicines and formulations … The government said – decision on the application of drug manufacturers On the increase in the maximum price of these medicines, the government said that the National Pharmaceutical Pricing Authority (NPPA) was continuously receiving applications from the manufacturers for increasing the prices of these medicines. The drug companies had cited the increase in the cost of medicines due to the increase in the prices of Active Pharmaceutical Ingredients (APIs) and changes in the exchange rate. The ministry said that the companies have also applied to discontinue some medicines due to their non-availability. Most of these medicines are cheap and are used for first-line treatment for the country’s public health programs. Read also… Government bans 156 fixed dose combination medicines: said – these pose a danger to humans, stop manufacturing and distribution immediately The government has banned 156 fixed dose combination (FDC) medicines. These were commonly used as painkillers, multi-vitamins and antibiotics apart from fever and cold. The government said that there is a possibility of danger to humans due to their use. Therefore, there will be a ban on the production, consumption and distribution of these medicines across the country. Read full news…
